Appointment Cancellation and No-Show Policy

Effective October 1, 2015, a 24 hour notice for appointment cancellation will be required. We sincerely appreciate your assistance and cooperation as this allows for a smooth office flow and more efficiently uses your time.  A $50 charge will be assessed to your account if an appointment is not timely cancelled or if you fail to show (no-show) for your appointment.  Thank you.

ONDAMED

ONDAMED treatments are now available at Partners in Obstetrics and Gynecology PLC.   ONDAMED treatments are useful for pain relief, improved circulation and promoting relaxation using focused EM-Fields with Pulse Biofeedback.  Read all about ONDAMED on www.ondamed.net or watch the You Tube video http://www.youtube.com/watch?v=j191PevUwyU

 

Call for an appointment:  319-233-8865

 

Mother’s exercise may boost baby’s brain

Mother’s exercise may boost baby’s brain
A new study done on pregnant rats showed pups whose mothers were allowed to run on wheels throughout pregnancy performed more dexterously in early childhood on a tricky memory test, and retained the cognitive advantage into adulthood. To follow, a study done at University of Montreal had women exercise at least 20 minutes 3 days per week, compared to a group of non-exercising women. After birth, the infant’s brain activity was recorded after stimulation with sound and essentially found the babies born of mothers who exercised were more mature. The long term benefits are still unknown, but physical activity during pregnancy may give an unborn child an advantage regarding brain development.

Hormone therapy and Menopause

Hormone therapy and Menopause
From Reviews in Obstetrics & Gynecology, 2013
A new global consensus statement has been released and published regarding hormone therapy after menopause. Menopause hormone therapy is the most effective treatment for hot flushes and sleep deprivation, but is also beneficial for bone health, and may decrease mortality and cardiovascular disease. The benefits of menopause hormone therapy outweigh the risk for women younger than 60 or within 10 years of menopause. Local/topical low-dose estrogen therapy is preferred for vaginal dryness. Estrogen-only therapy is appropriate for women without a uterus. Transdermal (not oral) therapy probably has a smaller risk of blood clots than oral medications, but the risk of this complication in women who are less than 60 is small. The risk of breast cancer is a more complex issue, and is related to progestogen therapy, but the risk is small and decreases after treatment is stopped. Bioidentical hormones are not recommended. The use of menopause hormone therapy should be individualized, with discussion or risks and benefits and the needs of each woman considered.